Quote For SkyePharma PLC SKP.L
sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
26 Nov 2009
90.75GBp
90.75p
26 Nov 2009
-4.97%
95.50p
92.25p
5,037
92.25p
90.50p
191.00p
74.75p
0.48
24,666
News
Press Releases
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Condella, Frank |
Non-Executive Chairman of the Board |
633,000 |
| Cunningham, Kenneth |
Chief Executive Officer, Executive Director |
575,000 |
| Grant, Peter |
Chief Financial Officer, Executive Director |
439,000 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
£22.87 |
| Shares Outstanding (Mil.) |
23.94 |
| Float (Mil.) |
23.80 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend (£ GBP) |
0.00 |
| Payout Ratio(TTM) % |
-- |
| |
| Financial Strength |
| Quick Ratio |
1.36 |
| Current Ratio |
1.11 |
| LT Debt/Equity |
-- |
| Total Debt/Equity |
-- |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
-- |
| Price/Sales(TTM) |
0.39 |
| Price/Book(TTM) |
-- |
| Price/Cash Flow(TTM) |
-- |
| |
|
| Per Share Data |
| Earnings(TTM) |
£-1.72 |
| Sales(TTM) |
£3.13 |
| Book Value(MRQ) |
£-3.40 |
| Cash Flow(TTM) |
£-1.23 |
| Cash(MRQ) |
£0.92 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
-- |
| Return on Assets(TTM) |
-29.08 |
| Return on Investment(TTM) |
-49.96 |
| |
|
| Margins |
| Gross Margin(TTM) % |
71.33 |
| Operating Margin(TTM) % |
-12.14 |
| Profit Margin(TTM) % |
-47.22 |
|
| |
|
UK
US
- Europe
- Asia
- UK Most Actives